Shuvaev, Sergey
Knipe, Rachel S.
Drummond, Matt
Rotile, Nicholas J.
Ay, Ilknur
Weigand-Whittier, Jonah P.
Ma, Hua
Zhou, Iris Yuwen
Roberts, Jesse D. Jr
Black, Katherine
Hariri, Lida P.
Ning, Yingying
Caravan, Peter http://orcid.org/0000-0002-3179-6537
Article History
Received: 14 July 2023
Revised: 14 July 2023
Accepted: 4 August 2023
First Online: 23 August 2023
Declarations
:
: All experiments and procedures were performed in accordance with the National Institutes of Health’s “Guide for the Care and Use of Laboratory Animals” and were approved by the Massachusetts General Hospital Institutional Animal Care and Use Committee.
: Financial interests: S.S., Y.N., and P.C. are inventors on a patent application that covers the compounds in this report. P.C. has equity in Reveal Pharmaceuticals and Collagen Medical and received consulting income from Collagen Medical. P.C. has received research funding from Janssen, Takeda, Pliant Therapeutics, and Transcode Therapeutics. All others authors declare no competing interests.